EPX and autoimmune disease: All anti-EPX/anti-ECP double-positive AEOSA+/ANCA− sera (6/6) were found in patients with a history of gastrointestinal tract disease and/or autoimmune disease (with 3/3 cases of ankylosing spondylitis).